Recent News

BriaCell Announces the Appointment of Biotechnology Veteran William Williams as New CEO and Director

Berkeley, CA and Vancouver, BC – October 26, 2016 – BriaCell Therapeutics Corp. (“BriaCell” or the “Company”) (TSXV: BCT) (OTCQB: BCTXF), a clinical-stage immuno-oncology company dedicated to the development of immuno-oncology treatments that can enhance the lives of cancer patients, is pleased to announce the appointment of Dr. William Williams, as its President, CEO and […]